2021 Managed Healthcare Executive® Pharmacy Survey: Biggest Driver in Specialty Drugs, Contract Changes Between Plan Sponsors and PBMs

June 14, 2021

In this part four series, participants give their opinions on the biggest driver of specialty drug expenditures this year and what the most significant change in contracts between plan sponsors and PBMs could be in the near future. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next few days.

2021 Managed Healthcare Executive® Pharmacy Survey: Most Effective Ways to Reduce Pharmaceutical Costs

June 12, 2021

In this part three series, participants give their opinions on the most effective ways to reduce traditional and specialty pharmaceutical costs. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.

COVID-19 Response in Japan, Sweden and the United States

February 01, 2021

Opinion piece by MHE's Editorial Advisory Board Member and CEO of The Pharmacy Group, Perry Cohen. Perry discusses the response differences and vague similarities between the countries and addresses the continuous question, "What is the new normal?"

Sumit Dutta of OptumRx on how the PBM Responded to Pandemic

December 23, 2020

In this week's episode, MHE's Senior Editor Peter Wehrwein spoke with Sumit Dutta, Optum Rx chief medical officer. The two spoke about COVID-19 vaccines and how the pharmacy benefit market responded to the pandemic.

Accumulator, Maximizer Regulation Picks up at the State Level

December 12, 2020

The five states have moved to prohibit accumulators and maximizers as the federal government takes a hands-off approach, according to John “Jack” S. Linehan, a lawyer at Epstein Becker Green, who is featured in this second part of a two-part video series.